Windlas Biotech Limited (WINDLAS.BO)
INR 924.95
(-0.21%)
INR 924.95
(-0.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -273.04 Million INR | -2189.06% |
| 2022 | 13.07 Million INR | -78.46% |
| 2021 | 60.67 Million INR | -63.05% |
| 2020 | 164.19 Million INR | 51.24% |
| 2019 | 108.56 Million INR | -42.84% |
| 2018 | 189.91 Million INR | -62.2% |
| 2017 | 502.38 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 100.0% |
| 2023 Q4 | -273.04 Million INR | -116.19% |
| 2023 Q1 | 1.31 Billion INR | 9997.02% |
| 2023 Q2 | 51.55 Million INR | -96.09% |
| 2023 FY | -273.04 Million INR | -2189.06% |
| 2023 Q3 | 1.68 Billion INR | 3171.45% |
| 2022 Q1 | 1.78 Billion INR | 2844.57% |
| 2022 Q4 | 13.07 Million INR | -99.27% |
| 2022 Q3 | 1.79 Billion INR | 1024.85% |
| 2022 FY | 13.07 Million INR | -78.46% |
| 2022 Q2 | -194 Million INR | -110.86% |
| 2021 Q3 | 1.99 Billion INR | 301.06% |
| 2021 FY | 60.67 Million INR | -63.05% |
| 2021 Q4 | 60.67 Million INR | -96.96% |
| 2021 Q2 | -991.43 Million INR | -282.74% |
| 2021 Q1 | 542.54 Million INR | 230.44% |
| 2020 FY | 164.19 Million INR | 51.24% |
| 2020 Q4 | 164.19 Million INR | -18.18% |
| 2020 Q3 | 200.66 Million INR | 0.0% |
| 2020 Q1 | 406.64 Million INR | 291.53% |
| 2019 Q4 | 103.86 Million INR | 0.0% |
| 2019 FY | 108.56 Million INR | -42.84% |
| 2018 FY | 189.91 Million INR | -62.2% |
| 2017 FY | 502.38 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 107.063% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 107.393% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 90.395% |
| Granules India Limited | 9.28 Billion INR | 102.94% |
| Indoco Remedies Limited | 6.47 Billion INR | 104.216% |
| Achyut Healthcare Limited | -3.74 Million INR | -7188.841% |
| Ajanta Pharma Limited | -954.9 Million INR | 71.406% |
| Alkem Laboratories Limited | -1.6 Billion INR | 83.035% |
| Alpa Laboratories Limited | 35.36 Million INR | 872.106% |
| Brooks Laboratories Limited | 49.48 Million INR | 651.763% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 94.553% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 108.277% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 76.416% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 102.114% |
| Eris Lifesciences Limited | 13.8 Billion INR | 101.978% |
| FDC Limited | -57.75 Million INR | -372.78% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 93.628% |
| Gufic Biosciences Limited | 3.19 Billion INR | 108.548% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 93.426% |
| Ipca Laboratories Limited | 11.41 Billion INR | 102.392% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 80.356% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 114.126% |
| Lasa Supergenerics Limited | 205.79 Million INR | 232.673% |
| Laurus Labs Limited | 24.38 Billion INR | 101.12% |
| Lupin Limited | 17.19 Billion INR | 101.588% |
| Mankind Pharma Limited | -9.9 Billion INR | 97.244% |
| Medicamen Biotech Limited | 160.31 Million INR | 270.314% |
| Medico Remedies Limited | 78.67 Million INR | 447.039% |
| Megasoft Limited | 1.28 Billion INR | 121.239% |
| NATCO Pharma Limited | -5.81 Billion INR | 95.306% |
| Piramal Pharma Limited | 42.27 Billion INR | 100.646% |
| RPG Life Sciences Limited | -364.7 Million INR | 25.133% |
| Sigachi Industries Limited | 859.94 Million INR | 131.751% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 99.623% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | 288.335% |
| Syncom Formulations (India) Limited | 46.21 Million INR | 690.855% |
| Unichem Laboratories Limited | 931.91 Million INR | 129.299% |
| Wanbury Limited | 1.1 Billion INR | 124.69% |
| ZIM Laboratories Limited | 983.6 Million INR | 127.759% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 106.98% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 71.009% |
| Divi's Laboratories Limited | -39.77 Billion INR | 99.313% |
| Hester Biosciences Limited | 2.29 Billion INR | 111.919% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 88.371% |
| Amrutanjan Health Care Limited | -248.79 Million INR | -9.746% |
| Bal Pharma Limited | 1.26 Billion INR | 121.609% |
| Strides Pharma Science Limited | 23.25 Billion INR | 101.174% |
| Venus Remedies Limited | -267.7 Million INR | -1.995% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 110.454% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 104.434% |
| Shilpa Medicare Limited | 9.06 Billion INR | 103.011% |
| Aarti Drugs Limited | 5.54 Billion INR | 104.921% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 75.207% |
| Suven Life Sciences Limited | -1.63 Billion INR | 83.277% |
| Ind-Swift Limited | 9.5 Billion INR | 102.872% |
| Valiant Laboratories Limited | -295.03 Million INR | 7.454% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 109.678% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 102.723% |
| Themis Medicare Limited | 764.96 Million INR | 135.693% |
| Hikal Limited | 7.96 Billion INR | 103.427% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 100.858% |
| Sequent Scientific Limited | 4.17 Billion INR | 106.534% |
| Novartis India Limited | -5.89 Billion INR | 95.365% |
| Wockhardt Limited | 18.27 Billion INR | 101.494% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 101.009% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | -1380.213% |
| Neuland Laboratories Limited | -214.05 Million INR | -27.554% |
| Morepen Laboratories Limited | -231.17 Million INR | -18.11% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | 327.459% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 127.981% |